Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IMM-124E by Immuron for Traveler's Diarrhea: Likelihood of Approval
IMM-124E is under clinical development by Immuron and currently in Phase II for Traveler's Diarrhea. According to GlobalData, Phase II...